James F. Parslow's most recent trade in Xenetic Biosciences Inc was a trade of 100,000 Common Stock done . Disclosure was reported to the exchange on April 21, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Xenetic Biosciences Inc | James F. Parslow | Interim CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2026 | 100,000 | 100,000 (1%) | 1% | 0 | Common Stock | |
| Xenetic Biosciences Inc | James F. Parslow | Interim CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 20,000 | 20,000 | - | - | Stock Options | |
| Xenetic Biosciences Inc | F. Parslow James | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2023 | 10,000 | 10,000 | - | - | Stock Options | |
| Xenetic Biosciences Inc | James F. Parslow | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 50,000 | 50,000 | - | - | Stock Options |